Recruiting Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy NCT06937177 Conditions Body Weight, Body Weight Changes, Cachexia, +20 more Locations Arizona Clinical Research Center — Tucson, Arizona, United States Cedars-Sinai Medical Center — Los Angeles, California, United States UCLA Medical Center — Santa Monica, California, United States Life Clinical Trials — Coral Springs, Florida, United States View all 26 locations View more locations Show fewer locations Loading locations... View Trial Details
